FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges
- DOI
- 10.1038/s44184-025-00174-2
- Published
- 2025-11-26
- Container
- npj Mental Health Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s44184-025-00174-2,
title = {FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges},
author = {Julian Herpertz and Ariel D. Stern and Nils Opel and Ulrich Reininghaus and John Torous},
year = {2025},
journal = {npj Mental Health Research},
doi = {10.1038/s44184-025-00174-2},
url = {https://doi.org/10.1038/s44184-025-00174-2}
}RIS
TY - JOUR TI - FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges AU - Julian Herpertz AU - Ariel D. Stern AU - Nils Opel AU - Ulrich Reininghaus AU - John Torous PY - 2025 JO - npj Mental Health Research DO - 10.1038/s44184-025-00174-2 UR - https://doi.org/10.1038/s44184-025-00174-2 ER -
APA
Herpertz, J., Stern, A. D., Opel, N., Reininghaus, U., & Torous, J. (2025). FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges. npj Mental Health Research. https://doi.org/10.1038/s44184-025-00174-2
Source records
- crossref · retrieved 2026-09-25T13:59:45.950Z